Skyrocketing demand and utilization of GLP-1s for weight loss in 2024 left employers looking to deploy strategies that maximize health impacts while managing costs and promoting equitable access. With demand continuing to rise, recent approvals for cardiovascular disease, and new indications expected soon, now is the time to reflect on lessons learned and adjust GLP-1 strategies for 2025 and the years ahead. 

Join senior benefits leaders for a candid conversation about: 

• Which GLP-1 strategies proved most effective in 2024, and which fell short of expectations
• The value that nutrition-first, drug-free alternatives play in creating a future-proofed GLP-1 strategy optimized for access, cost and employee experience
• What challenges benefits leaders should be prepared to address in 2025

Location & Time

Webinar

December 10, 12:00 p.m. - December 10, 01:00 p.m. E.T.

Speakers

• Christy Carver, Director of Corporate Benefits, Cubic Corporation
• Kristy Lucksinger, Head of Global Benefits, JLL
• Leslie Archer, Manager of Company Wellness and Benefits Communications, Syneos Health
• Trent Myers, VP, Virta Health